Advicenne S.A. (EPA:ALDVI)
France
· Delayed Price · Currency is EUR 1.744
-0.016 (-0.91%)
Jun 17, 2025, 2:45 PM CET
Advicenne Revenue
In the year 2024, Advicenne had annual revenue of 5.27M EUR, down -0.51%. Advicenne had revenue of 3.50M in the half year ending December 31, 2024, with 237.42% growth.
Revenue
5.27M
Revenue Growth
-0.51%
P/S Ratio
4.10
Revenue / Employee
405.23K
Employees
13
Market Cap
21.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.27M | -27.00K | -0.51% |
| Dec 31, 2023 | 5.30M | 1.58M | 42.53% |
| Dec 31, 2022 | 3.72M | -9.00K | -0.24% |
| Dec 31, 2021 | 3.72M | 233.00K | 6.67% |
| Dec 31, 2020 | 3.49M | 907.00K | 35.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |